Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A general NIH website-transition notice appears above the page’s 403 error, and the site revision number is updated.
    Difference
    1%
    Check dated 2026-10-21T13:41:53.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T13:27:31.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with an '403 Forbidden' page, replacing the previous study record content. This means the trial details and related information are no longer accessible on this page.
    Difference
    19%
    Check dated 2026-09-23T19:54:56.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new revision tag was added (Revision: v3.7.0), replacing the previous Revision: v3.6.6 to indicate a version update.
    Difference
    0.0%
    Check dated 2026-09-16T21:36:37.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The site underwent a small frontend revision, upgrading from v3.6.5 to v3.6.6, indicating an incremental update to the interface and internal components rather than substantive changes to study details.
    Difference
    0.0%
    Check dated 2026-09-02T18:13:07.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added a line in the Study Details noting the 2015 NIH grant/contract, linking the study to NIH funding information.
    Difference
    0.0%
    Check dated 2026-08-26T19:44:28.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.